CoChat

Metabolic tests to determine risk for type 1 diabetes in clinical trials

Open access
Greenbaum, Carla J., Buckingham, B., Chase, H. P., Krischer, J., for the Diabetes Prevention Trial, Type 1 Diabetes (DPT‐1) Study Group · 2011 · Diabetes/Metabolism Research and Reviews
Cited by 12

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Aims: Evaluate the reproducibility and relationship of various metabolic tests conducted as part of the Diabetes Prevention Trial—type 1 diabetes. Methods: Coefficients of variation, intraclass correlation coefficients, and Pearson correlations between the same metabolic tests performed at different times as well as the different tests were determined. Results: Fasting samples on the same day had a coefficient of variation of < 10 for C‐peptide, 11 for insulin, and 2 for glucose. Testing on separate days approximately doubled the variance. Stimulated insulin values had less variance than fasting values and there was only a moderate correlation between fasting and stimulated values on each test. While highly correlated, C‐peptide values from mixed meal tolerance tests are significantly lower than that obtained during oral glucose tolerance tests (OGTTs). Neither peak nor area under the curve C‐peptide on the oral glucose tolerance test was different between those with abnormal and normal glucose tolerance. Those with abnormal as compared with normal glucose tolerance had lower 30‐min C‐peptide and a longer time to peak C‐peptide. Conclusions: A large, multi‐centre trial, with tests performed over a decade‐long period, can provide robust data. C‐peptide data from oral glucose tolerance tests and mixed meal tolerance tests differ; therefore, the same stimulation test should be used to evaluate changes in beta cell function over time. Worsening glucose tolerance is associated with lower C‐peptide at 30 min and a delay in peak secretion on the oral glucose tolerance test. This Diabetes Prevention Trial—type 1 diabetes data can be used in planning parameters for future studies, including evaluation of new algorithms to determine risk of disease. Copyright © 2011 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.1205

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 12

Metadata

Authors
Greenbaum, C. J., Buckingham, B., Chase, H. P., Krischer, J., & for the Diabetes Prevention Trial, T. 1. D. (. S. G.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2011-09
Volume
27
Issue
6
Pages
584-589
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W2062975415
Cited by
12
References
2
FWCI
0.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic tests to determine risk for type 1 diabetes in clinical trials. https://app.cochat.ai/papers/10.1002/dmrr.1205
The paper
Greenbaum, C. J., Buckingham, B., Chase, H. P., Krischer, J., & for the Diabetes Prevention Trial, T. 1. D. (. S. G. (2011). Metabolic tests to determine risk for type 1 diabetes in clinical trials. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.1205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.